About this document
Advances in Anti-TB Drugs for MDR-TB by malik003 is a document available to read on EtoBox.
1) Tuberculosis remains a major global health problem and a leading cause of death. The emergence of multidrug-resistant TB poses challenges for treatment and control. 2) New drugs are urgently needed to improve treatment of multidrug-resistant TB by shortening treatment duration, improving outcomes, and reducing mortality. 3) Several novel investigational drugs targeting non-traditional pathways have entered clinical trials and may help develop better regimens for multidrug-resistant TB.
- Author
- malik003
- Language
- EN